SG11202105579VA - Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect - Google Patents

Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect

Info

Publication number
SG11202105579VA
SG11202105579VA SG11202105579VA SG11202105579VA SG11202105579VA SG 11202105579V A SG11202105579V A SG 11202105579VA SG 11202105579V A SG11202105579V A SG 11202105579VA SG 11202105579V A SG11202105579V A SG 11202105579VA SG 11202105579V A SG11202105579V A SG 11202105579VA
Authority
SG
Singapore
Prior art keywords
elastin
agent
elafine
composite
inhibiting
Prior art date
Application number
SG11202105579VA
Other languages
English (en)
Inventor
Sota Akazawa
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11202105579VA publication Critical patent/SG11202105579VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202105579VA 2018-12-27 2019-12-24 Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect SG11202105579VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018245318 2018-12-27
PCT/JP2019/050479 WO2020138023A1 (ja) 2018-12-27 2019-12-24 変性エラスチンの分解低下の抑制剤、正常なエラスチン線維の維持剤、エラスチン－エラフィン複合体形成抑制剤及びエラスチン－エラフィン複合体形成抑制作用を有する物質のスクリーニング方法

Publications (1)

Publication Number Publication Date
SG11202105579VA true SG11202105579VA (en) 2021-07-29

Family

ID=71125747

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105579VA SG11202105579VA (en) 2018-12-27 2019-12-24 Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect

Country Status (10)

Country Link
US (1) US20220062159A1 (enExample)
EP (1) EP3903885A4 (enExample)
JP (2) JP7663359B2 (enExample)
KR (1) KR20210109556A (enExample)
CN (1) CN113316472A (enExample)
AU (1) AU2019417521A1 (enExample)
CA (1) CA3120845A1 (enExample)
SG (1) SG11202105579VA (enExample)
TW (1) TWI887225B (enExample)
WO (1) WO2020138023A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7500380B2 (ja) * 2020-10-05 2024-06-17 株式会社ナリス化粧品 皮膚光老化予防改善剤のスクリーニング方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3583108B2 (ja) * 2002-03-14 2004-10-27 株式会社ノエビア 皮膚外用剤
JP2004182687A (ja) * 2002-12-05 2004-07-02 Kao Corp エラスターゼ阻害剤
JP5057638B2 (ja) 2003-11-27 2012-10-24 共栄化学工業株式会社 皮膚外用剤
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
JP4939766B2 (ja) * 2005-04-13 2012-05-30 株式会社 資生堂 基底膜安定化剤
US20110038814A1 (en) * 2007-08-27 2011-02-17 Emilie Rogg-Le Claire Tryptase inhibiting mustard extract
JP5970148B2 (ja) * 2008-09-12 2016-08-17 丸善製薬株式会社 チロシナーゼ活性阻害剤、メラニン産生抑制剤、及びＳＣＦｍＲＮＡ発現抑制剤
GB0902040D0 (en) * 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
CN102670423A (zh) * 2011-03-14 2012-09-19 日本乐敦制药株式会社 弹性蛋白酶活性抑制剂
JP5878714B2 (ja) * 2011-09-15 2016-03-08 一丸ファルコス株式会社 リンパ管腔形成促進剤
CA2896646A1 (en) * 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
JP6244594B2 (ja) * 2013-03-12 2017-12-13 株式会社東洋新薬 老化抑制剤
FR3010906B1 (fr) * 2013-09-25 2016-12-23 Expanscience Lab Extrait lipidique de graines de passiflores
IL259007B2 (en) * 2016-08-17 2024-07-01 Orthogen Ag Anti-ageing pharmaceutical preparation

Also Published As

Publication number Publication date
JPWO2020138023A1 (ja) 2021-10-21
JP2023078477A (ja) 2023-06-06
EP3903885A4 (en) 2022-10-12
AU2019417521A1 (en) 2021-06-17
EP3903885A1 (en) 2021-11-03
TW202038984A (zh) 2020-11-01
CN113316472A (zh) 2021-08-27
JP7663359B2 (ja) 2025-04-16
WO2020138023A1 (ja) 2020-07-02
KR20210109556A (ko) 2021-09-06
US20220062159A1 (en) 2022-03-03
TWI887225B (zh) 2025-06-21
CA3120845A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
IL253742B (en) Method and system for managing encryption keys
SG10201908697XA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
EP3244831A4 (en) Multi-layer skin substitute products and methods of making and using the same
IL279530A (en) Benzodiazepine history, preparations, and methods for the treatment of cognitive disorder
RS67120B1 (sr) Brava i postupak učvršćivanja
GB2572291B (en) System and process for treating produced and frac flowback waters
EP3571942A4 (en) ELECTRONIC CIGARETTE AND UNLOCKING METHOD FOR ELECTRONIC CIGARETTE
GB2573257B (en) Method and machine for producing titanium cobbles
HUE072743T2 (hu) Komplementrendszer antagonistái paraproteinémiás neuropátiák kezelési eljárásaiban történõ alkalmazásra
ZA201800360B (en) Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
IL267139A (en) Method for the production of 5-(1-phenyl-h1-pyrazol-4-yl)-nicotinamide derivatives and similar compounds without isolation or purification of the phenylhydrazine intermediate
ZA201800780B (en) Methods for inhibiting the deposition of organic contaminants in pulp and papermaking systems
PL3245349T3 (pl) Pręt wzmacniający z wiązki włókien i sposób jego wytwarzania
GB201904357D0 (en) Vacancy matching method and application
SG10201706291TA (en) Composition And Method For Treating Skin Conditions
EP3801620A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATITIS
SG11202105579VA (en) Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect
EP3277419A4 (en) Tubular and vesicular architectures formed from polymer-lipid blends and method for forming the same
GB2564217B (en) Agent and method for hair cleansing
PL3642021T3 (pl) Kompozyt wielomateriałowy i sposób jego wytwarzania
GB202214988D0 (en) Compositions and methods for preventing or treating nephrolithiasis
HUE056312T2 (hu) Kompozit üveglap és eljárás elõállítására
SG11202112883PA (en) Laminate and method for producing same
EP4003518A4 (en) METHODS AND AGENTS FOR THE TREATMENT OF ACUTE NEUROINFLAMMATORY DAMAGE
SG11202102416SA (en) Methods for treating pancreatitis